back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-08-24 12:56 Tx date 2026-08-20 |
$HLS
HLS Therapeutics Inc. |
Millian, Craig
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,365
+500 vol $2.73 each |
17,000 | |
| Filed 2026-08-18 15:16 Tx date 2026-08-17 |
$HLS
HLS Therapeutics Inc. |
Millian, Craig
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,580
+2,000 vol $2.79 each |
16,500 | |
| Filed 2026-06-30 14:23 Tx date 2026-06-26 |
$HLS
HLS Therapeutics Inc. |
Millian, Craig
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
$509,219
+123,000 vol $4.14 each |
123,000 | |
| Filed 2026-06-30 14:22 Tx date 2023-05-01 |
$HLS
HLS Therapeutics Inc. |
Millian, Craig
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-06-17 15:49 Tx date 2026-06-17 |
$HLS
HLS Therapeutics Inc. |
Millian, Craig
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,320
+2,000 vol $3.16 each |
14,500 | |
| Filed 2025-03-19 12:05 Tx date 2025-03-17 |
$HLS
HLS Therapeutics Inc. |
Millian, Craig
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,142,850
+285,000 vol $4.01 each |
1,185,000 | |
| Filed 2024-05-16 10:13 Tx date 2024-05-15 |
$HLS
HLS Therapeutics Inc. |
Millian, Craig
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,250
+2,500 vol $2.90 each |
12,500 | |
| Filed 2024-05-15 11:20 Tx date 2024-05-13 |
$HLS
HLS Therapeutics Inc. |
Millian, Craig
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,182,000
+300,000 vol $3.94 each |
900,000 | |
| Filed 2023-11-17 14:15 Tx date 2023-11-16 |
$HLS
HLS Therapeutics Inc. |
Millian, Craig
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$13,000
+5,000 vol $2.60 each |
10,000 | |
| Filed 2023-05-19 13:11 Tx date 2023-05-16 |
$HLS
HLS Therapeutics Inc. |
Millian, Craig
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$2,742,000
+600,000 vol $4.57 each |
600,000 | |
| Filed 2023-05-19 13:11 Tx date 2023-05-01 |
$HLS
HLS Therapeutics Inc. |
Millian, Craig
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-05-19 13:10 Tx date 2023-05-19 |
$HLS
HLS Therapeutics Inc. |
Millian, Craig
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,800
+2,000 vol $3.40 each |
5,000 | |
| Filed 2023-05-15 13:58 Tx date 2023-05-15 |
$HLS
HLS Therapeutics Inc. |
Millian, Craig
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,158
+3,000 vol $3.39 each |
3,000 | |
| Filed 2023-05-15 13:57 Tx date 2023-05-01 |
$HLS
HLS Therapeutics Inc. |
Millian, Craig
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|